Shereen Elkholy

Dr. Shereen Elkholy

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2006 in In Vitro Cellular & Developmental Biology - Plant
Verified
Journal Article
Closed access
PDF file
Pamela WeathersPamela Weathers
Pamela Weathers
SEShereen Elkholy
Shereen Elkholy
KWKristin K. Wobbe
Kristin K. Wobbe
Artemisinin is a sesquiterpene lactone isolated from the aerial parts of Artemisia annua L. plants. Besides being currently the best therapeutic against both drug-resistant and cerebral malaria-causing strains of Plasmodium falciparum, the drug has also been shown to be effective against other infections diseases including schistosomiasis and hepatitis. More recently, it has also been shown to be effective against numerous types of tumors. Although chemical synthesis of artemisinin is possible, it is not economically feasible. The relatively low yield (0.01–0.8%) of artemisinin in A. annua is a further serious limitation to the commercialization of the drug. Therffore, the enhanced production of artemisinin either in cell/tissue culture or in the whole plant of A. annua is highly desirable. A better understanding of the biochemical pathway leading to the synthesis of artemisinin and its regulation by both exogenous and endogenous factors is essential for facilitating increased yield. Two genes of the artemisinin biosynthetic pathway have now been identified. This critical review covers recent developments related to the biosynthesis of this important compound and related terpenoids, their regulation, and the production of these compounds both in vitro and in whole plants.

11 July 2008 in Planta Medica
Verified
Journal Article
Closed access
PDF file
MSMahmoud Sharaf-Eldin
Mahmoud Sharaf-Eldin
SEShereen Elkholy
Shereen Elkholy
JFJosé-Antonio Fernández
José-Antonio Fernández
HJHelmut Junge
Helmut Junge
RCRonald Cheetham
Ronald Cheetham
PWPamela Weathers
Pamela Weathers
The effect of Bacillus subtilis FZB24® on saffron (Crocus sativus L.) was studied using saffron corms from Spain and the powdered form of B. subtilis FZB24®. Corms were soaked in water or in B. subtilis FZB24 spore solution for 15 min before sowing. Some corms were further soil drenched with the spore solution 6, 10 or 14 weeks after sowing. Growth and saffron stigma chemical composition were measured. Compared to untreated controls, application of B. subtilis FZB24 significantly increased leaf length, flowers per corm, weight of the first flower stigma, total stigma biomass; microbe addition also significantly decreased the time required for corms to sprout and the number of shoot sprouts. Compared to the controls, picrocrocin, crocetin and safranal compounds were significantly increased when the plants were soil drenched with the spore solution 14 weeks after sowing; in contrast crocin was highest in untreated controls. Results of this study suggest that application of B. subtilis FZB24® may provide some benefit to saffron growers by speeding corm growth (earlier shoot emergence) and increasing stigma biomass yield by 12 %. While some treatment conditions also increased saffron chemical composition, these were generally not the same treatments that simultaneously improved growth yields and thus, more study is required.

15 June 2002 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
RSReinhold Schirmbeck
Reinhold Schirmbeck
DSDetlef Stober
Detlef Stober
SEShereen Elkholy
Shereen Elkholy
PRPetra Riedl
Petra Riedl
JRJörG Reimann
JörG Reimann
MHC-I-restricted CTL responses of H-2d (Ld+ or Ld−) and F1 H-2dxb mice to hepatitis B surface Ag (HBsAg) are primed by either DNA vaccines or HBsAg particles. The Dd/S201–209 and Kd/S199–208 epitopes are generated by processing endogenous HBsAg; the Kb/S208–215 epitope is generated by processing exogenous HBsAg; and the Ld/S28–39 epitope is generated by exogenous as well as endogenous processing of HBsAg. DNA vaccination primed high numbers of CTL specific for the Ld/S28–39 HBsAg epitope, low numbers of CTL specific for the Dd/S201–209 or Kd/S199–208 HBsAg epitopes in BALB/c mice, and high numbers of Dd/S201–209- and Kd/S199–208-specific CTL in congenic H-2d/Ld− dm2 mice. In F1dxb mice, the Kd-, Dd-, and Kb-restricted CTL responses to HBsAg were strikingly suppressed in the presence but efficiently elicited in the absence of Ld/S28–39-specific CTL. Once primed, the Kd- and Dd-restricted CTL responses to HBsAg were resistant to suppression by immunodominant Ld/S28–39-specific CTL. The Ld-restricted immunodominant CTL reactivity to HBsAg can thus suppress priming to multiple alternative epitopes of HBsAg, independent of the processing pathway that generates the epitope, of the background of the mouse strain used, and of the presence/absence of different allelic variants of the K and D MHC class I molecules.

11 April 2017 in 3 Biotech
Verified
Journal Article
Open access
PDF file
Pravej AlamPravej Alam
Pravej Alam
ZKZainul Abdeen Khan
Zainul Abdeen Khan
MAMalik Zainul Abdin
Malik Zainul Abdin
JKJawaid A. Khan
Jawaid A. Khan
Parvaiz AhmadParvaiz Ahmad
Parvaiz Ahmad
MSMahmoud A. Sharaf-Eldin
Mahmoud A. Sharaf-Eldin
Catharanthus roseus is an important medicinal plant known for its pharmacological qualities such as antimicrobial, anticancerous, antifeedant, antisterility, antidiabetic activities. More than 130 bioactive compounds like vinblastine, vindoline and vincristine have been synthesized in this plant. Extensive studies have been carried out for optimization regeneration and transformation protocols. Most of the protocol described are laborious and time-consuming. Due to sophisticated protocol of regeneration and genetic transformation, the production of these bioactive molecules is less and not feasible to be commercialized worldwide. Here we have optimized the efficient protocol for regeneration and transformation to minimize the time scale and enhance the transformation frequency through Agrobacterium and sonication-assisted transformation (SAAT) method. In this study, hypocotyl explants responded best for maximal production of transformed shoots. The callus percentage were recorded 52% with 1.0 mg L−1 (BAP) and 0.5 mg L−1 (NAA) while 80% shoot percentage obtained with 4.0 mg L−1 (BAP) and 0.05 mg L−1 (NAA). The microscopic studies revealed that the expression of GFP was clearly localized in leaf tissue of the C. roseus after transformation of pRepGFP0029 construct. Consequently, transformation efficiency was revealed on the basis of GFP localization. The transformation efficiency of SAAT method was 6.0% comparable to 3.5% as conventional method. Further, PCR analysis confirmed the integration of the nptII gene in the transformed plantlets of C. roseus.

1 August 2002 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
PRPetra Riedl
Petra Riedl
SEShereen Elkholy
Shereen Elkholy
JRJörG Reimann
JörG Reimann
RSReinhold Schirmbeck
Reinhold Schirmbeck
The immunodominant, conformational “a” determinant of hepatitis B surface Ag (HBsAg) elicits Ab responses. We selectively expressed the Ab-binding, glycosylated, native a determinant (residue 120–147) of HBsAg in a fusion protein containing C-terminally the HBsAg fragment SII (residue 80–180) fused to a SV40 T-Ag-derived hsp73-binding 77 aa (T77) or non-hsp-binding 60 aa (T60) N terminus. A DNA vaccine encoding non-hsp-binding secreted T60-SII fusion protein-stimulated murine Ab responses with a similar efficacy as a DNA vaccine encoding the secreted, native, small HBsAg. A DNA vaccine encoding hsp73-binding, intracellular T77-SII fusion protein-stimulated murine Ab responses less efficiently but comparable to a DNA vaccine encoding the intracellular, native, large HBsAg. HBsAg-specific Abs elicited by either the T60-SII-expressing or the T77-SII-expressing DNA vaccine suppressed HBsAg antigenemia in transgenic mice that produce HBsAg from a transgene in the liver; hence, a biologically active B cell response cross-reacting with the native, viral envelope epitope was primed by both DNA vaccine constructs. HBsAg-specific Ab and CTL responses were coprimed when an S20–50 fragment (containing the immunodominant, Ld-binding epitope S28–39) of HBsAg was fused C-terminally to the pCI/T77-SII sequence (pCI/T77-SII-Ld DNA vaccine). Chimeric, polyepitope DNA vaccines encoding conformational, Ab-binding epitopes and MHC class I-binding epitopes can thus efficiently deliver antigenic information to different compartments of the immune system in an immunogenic way.

28 August 2007 in Planta Medica
Verified
Journal Article
Closed access
MSM. A. Sharaf-Eldin
M. A. Sharaf-Eldin
SEShereen Elkholy
Shereen Elkholy
JFJ. A. Fernández
J. A. Fernández
HJH. Junge
H. Junge
RCR. D. Cheetham
R. D. Cheetham
PWP. J. Weathers
P. J. Weathers
The effect of Bacillus subtilis FZB24® on saffron (Crocus sativus L.) was studied at Worcester Polytechnic Institute (WPI), USA, using saffron corms provided by Universidad de Castilla-La Mancha (UCLM), Spain and the powder form of B. subtilis FZB24® provided by FZB Biotechnik GmbH, Germany [1,2]. Saffron corms were soaked in water for 15min before sowing (T1=C.: untreated control), corms of treatment two (T2) were soaked in B. subtilis FZB24 solution at 2g/1000ml water for 15min, while corms of T3, T4 and T5 were drenched with FZB24at 2g/10 L after 6, 10 or 14 wks of sowing date, respectively. The following parameters were evaluated starting from sowing date: days to sprout, number of sprouts and leaf length after 10 wks, days to flower, number of flowers/corm, FW of stigma yield [g]/1st flower and total stigma FW [g]/corm. Chemical analysis of stigmas showed that B. subtilis FZB24 altered the crocin, picrocrocin, crocetin and safranal contents of saffron compared to the untreated control. In contrast, there were no significant differences in vegetative growth. These results will prove useful in the implementation and improvement of saffron production technology. Acknowledgements: Support for this research provided in part by the ICSC-World Laboratory Scholarship, Switzerland to Dr. M.A. Sharaf-Eldin. References: [1] Kilian, M. et al. (2000) Pflanzenschutz-Nachrichten Bayer 1: 72–93. [2] Krebs, B. et al. (1998) JPDP 105: 181–197.